Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




New DNA Test for Colorectal Cancer

By HospiMedica staff writers
Posted on 10 Dec 2001
A new DNA-based colorectal cancer test is not a predictive test but a test to detect the presence of actual disease in people with hereditary non-polyposis colorectal cancer (HNPCC). More...
People with HNPCC have an 80% lifetime risk of developing the disease.

The test, a stool-sample test called PreGen-26, is based on proprietary genomics technology of Exact Sciences Corp. (Maynard, MA, USA) and is being commercialized by Laboratory Corporation of America (LabCorp, Burlington, NC, USA). In active colorectal cancer, DNA from tumors is shed into the colon and carried out of the body in stool. Patients will collect stool samples and send them to LabCorp. After using the test to analyze stool samples, the company will send the test results to the patient's doctor for use in determining future monitoring and treatment.

"LabCorp's offering of PreGen-26 reaffirms our commitment to apply today's knowledge of genetics to yield improved clinical information for physicians and patients,” said Thomas P. MacMahon, chairman and CEO of LabCorp.





Related Links:
Exact Sciences
LabCorp

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Tourniquet System
heidi– mein Tourniquet
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.